Q44.6
Cystic disease of liver
Clinical Classification Guidelines
Inclusion Terms
- Fibrocystic disease of liver
Medical Intelligence & Overview
Cystic disease of the liver, also known as fibrocystic disease of the liver, is a condition characterized by the development of multiple cysts within the liver tissue. These cysts are fluid-filled sacs that can vary in size and number. While some cysts may cause no symptoms and require no treatment, others can lead to complications and impact liver function. Recognizing the features of this disease helps in managing and monitoring the condition effectively.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to inherited disorders such as polycystic liver disease Congenital conditions present from birth Progression of other cystic or fibrocystic diseases of the liver Unknown causes in some cases, where no specific factor is identified
Key Symptoms: Often asymptomatic, especially in early stages Abdominal fullness or discomfort Enlarged liver, detectable through physical examination Pain or tenderness in the upper right abdomen Nausea in some cases Increased risk of infection within cysts, leading to fever or infections Potential complications such as cyst rupture or bleeding
Diagnostic & Treatment
Diagnosis Path: Diagnosis of fibrocystic liver disease involves a combination of clinical evaluation and imaging tests. Common diagnostic methods include:
Treatment Protocols: Management of cystic disease of the liver depends on the severity and symptoms. In many cases, no treatment is required if cysts are small and asymptomatic. When intervention is necessary, options include:
Clinical Advice & FAQs
Billing Guidance
Is Q44.6 a billable ICD-10 code?
Yes, Q44.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q44.6?
Clinical documentation must specify the nature of Cystic disease of liver and any associated comorbidities for accurate reporting.
Cite this Clinical Reference